Gujarat Themis Biosyn Promoter Acquires Shares Worth ₹20 Cr

Sachin D. Patel, a promoter of Gujarat Themis Biosyn Limited, has disclosed plans to acquire up to 5,25,000 equity shares, representing approximately 0.50% of the total share capital. The acquisition is from Pharmaceutical Business Group (India) Limited and is classified as an inter-se transfer within the promoter group. The proposed acquisition price is ₹395.75 per equity share, with a total transaction value not exceeding ₹20 Crores. This transaction is exempt from making an open offer under Regulation 10(1)(a)(ii) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The acquisition is scheduled to take place between July 8, 2026, and July 14, 2026. The acquirer has declared compliance with relevant SEBI regulations.